530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study). (September 2015) - Iguchi, H.; Suzuki, N.; Uesugi, K.; Tanaka, H.; Hirakawa, K.; Aruga, A.; Hatori, T.; Ishizaki, H.; Umeda, Y.; Fujiwara, T.; Shimada, M.; Ikemoto, T.; et al.